| |
Donors
|
Recipients
|
Donors
|
Recipients
|
|
Sex
| | | | |
|
Female
|
41
|
27
|
14
|
7
|
|
Male
|
44
|
58
|
18
|
25
|
|
Age at transplant (years)
| | | | |
|
Median
|
48
|
52
|
53
|
55
|
|
Range
|
14–72
|
21–66
|
22–71
|
23–64
|
|
CMV serostatus
| | | | |
|
Positive
|
38
|
43
|
14
|
11
|
|
Negative
|
31
|
32
|
16
|
21
|
|
NA
|
16
|
10
|
2
|
0
|
|
Max. acute GVHD
| | | | |
|
Absent
|
–
|
39
|
–
|
15
|
|
Grade I ('mild')
|
–
|
24
|
–
|
3
|
|
Grade II ('mild')
|
–
|
13
|
–
|
5
|
|
Grade III ('severe')
|
–
|
8
|
–
|
7
|
|
Grade IV ('severe')
|
–
|
1
|
–
|
2
|
|
Max. chronic GVHD
| | | | |
|
Absent
|
–
|
54
|
–
|
2
|
|
Limited
|
–
|
21
|
–
|
10
|
|
Extensive
|
–
|
9
|
–
|
3
|
|
NA
|
–
|
1
|
–
|
17
|
|
Diagnosis
| | | | |
|
Acute lymphoblastic leukemia
|
–
|
1
|
–
|
1
|
|
Acute myeloid leukemia
|
–
|
17
|
–
|
8
|
|
Chronic granulomatous disease
|
–
|
1
|
–
|
0
|
|
Chronic lymphocytic leukemia (CLL)
|
–
|
11
|
–
|
0
|
|
Chronic myeloid leukemia (CML)
|
–
|
0
|
–
|
3
|
|
Chronic myelomonocytic leukemia
|
–
|
1
|
–
|
0
|
|
Hodgkin lymphoma
|
–
|
9
|
–
|
4
|
|
Myelodysplasia (MDS)
|
–
|
2
|
–
|
0
|
|
MDS/CML/CLL
|
–
|
1
|
–
|
0
|
|
Myelofibrosis
|
–
|
0
|
–
|
2
|
|
Myeloproliferative syndromes/MDS
|
–
|
0
|
–
|
2
|
|
Myeloma
|
–
|
3
|
–
|
0
|
|
Non-Hodgkin lymphoma
|
–
|
37
|
–
|
8
|
|
Other
|
–
|
0
|
–
|
4
|
|
NA
|
–
|
2
|
–
|
0
|
| |
Sibling pairs
|
Sibling pairs
|
|
Sex match (donor/recipient)
| | |
|
Male/male
|
30
|
14
|
|
Female/female
|
13
|
3
|
|
Male/female
|
14
|
4
|
|
Female/male
|
28
|
11
|
|
CMV match (donor/recipient)
| | |
|
Negative/negative
|
18
|
13
|
|
Positive/positive
|
25
|
8
|
|
Negative/positive
|
13
|
3
|
|
Positive/negative
|
13
|
6
|
|
NA
|
16
|
2
|
